New hope for myeloma patients with chromosome issues
NCT ID NCT00572169
First seen Feb 05, 2026 · Last updated May 23, 2026 · Updated 11 times
Summary
This study tests a new treatment plan for people newly diagnosed with multiple myeloma, a type of blood cancer. It combines several drugs and a stem cell transplant to see if it works better than previous treatments, especially for those with certain chromosome changes. The goal is to improve outcomes, but patients will need ongoing maintenance therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Arkansas for Medical Sciences/Myeloma Institute
Little Rock, Arkansas, 72205, United States
Conditions
Explore the condition pages connected to this study.